课题基金 / 基金详情

Host and parasite factors influencing P. vivax RBC invasion and asexual development

Host and parasite factors influencing P. vivax RBC invasion and asexual development
影响间日疟原虫红细胞侵袭和无性发育的宿主和寄生虫因素
批准号:
10641026
负责人:
David Serre
金额:
$70.63万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-06-08 至 2027-05-31

项目摘要

项目成果

David Serre的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract Plasmodium vivax threatens half of the world’s population and is surprisingly resilient to on-going malaria elimination efforts, partially due to its unique characteristics and our poor understanding of its biology. Here, we propose to conduct state-of-the-art transcriptomic analyses using materials derived directly from Cambodian patients to rigorously assess the importance of red blood cell polymorphisms, host immunity and parasite factors in modulating the efficacy of red blood cell invasion and P. vivax intraerythrocytic development. Our studies will not only provide a better understanding of the fundamental molecular and cellular processes underlying blood stage P. vivax infections but will also provide a solid foundation to develop better malaria vaccines against this important but understudied human pathogen.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-Omics Characterization of Plasmodium Vivax Hypnozoites
  • 批准号:
    10565802
  • 项目类别:
  • 资助金额:
    $72.51万
  • 财政年份:
    2022
  • 负责人:
    David Serre
  • 依托单位:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
  • 批准号:
    10372166
  • 项目类别:
  • 资助金额:
    $23.18万
  • 财政年份:
    2021
  • 负责人:
    David Serre
  • 依托单位:
Design and Evaluation of a Plasmodium vivax ultra-dense peptide array
  • 批准号:
    10189044
  • 项目类别:
  • 资助金额:
    $19.31万
  • 财政年份:
    2021
  • 负责人:
    David Serre
  • 依托单位:
Rigorous Assessment of P. vivax Relapses and Primaquine Efficacy for Radical Cure
  • 批准号:
    10469663
  • 项目类别:
  • 资助金额:
    $64.43万
  • 财政年份:
    2020
  • 负责人:
    David Serre
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究